We are live on
!
Find out more
NIM
NEOS Investment Management Portfolio holdings
AUM
$27.1B
1-Year Est. Return
57.21%
This Fund
S&P 500
This Quarter
Est. Return
+13.42%
1 Year Est. Return
+57.21%
3 Year Est. Return
+163.05%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.61B
AUM Growth
+$558M
(+53%)
Cap. Flow
+$437M
Cap. Flow
% of AUM
27.05%
Top 10 Holdings %
Top 10 Hldgs %
34.09%
Holding
582
New
73
Increased
454
Reduced
38
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$29.1M |
| 2 |
Apple
AAPL
|
+$26.2M |
| 3 |
NVIDIA
NVDA
|
+$19.5M |
| 4 |
Amazon
AMZN
|
+$16.9M |
| 5 |
Meta Platforms (Facebook)
META
|
+$10.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Russell 2000 ETF
VTWO
|
+$12.5M |
| 2 |
SPLK
Splunk Inc
SPLK
|
+$848K |
| 3 |
Goldman Sachs
GS
|
+$583K |
| 4 |
IMGN
Immunogen Inc
IMGN
|
+$523K |
| 5 |
Travelers Companies
TRV
|
+$514K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.78% |
| 2 | Healthcare | 14.59% |
| 3 | Communication Services | 10.45% |
| 4 | Consumer Discretionary | 10.42% |
| 5 | Financials | 8.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Teva Pharmaceutical Industries Limited
TEVA
$45B
| $281K | 0.02% |
+19,932
| New | +$251K |
|
502
Cullinan Oncology
CGEM
$1.32B
| $279K | 0.02% |
16,388
+482
| +3% | +$7.45K |
|
503
Sarepta Therapeutics
SRPT
$2.17B
| $273K | 0.02% |
+2,112
| New | +$259K |
|
504
LKQ Corp
LKQ
$5.95B
| $272K | 0.02% |
+5,084
| New | +$252K |
|
505
Evergy
EVRG
$18.7B
| $271K | 0.02% |
+5,084
| New | +$260K |
|
|
SWTX
506
DELISTED
SpringWorks Therapeutics
SWTX
| $268K | 0.02% |
+5,450
| New | +$252K |
|
|
JNPR
507
DELISTED
Juniper Networks
JNPR
| $265K | 0.02% |
+7,140
| New | +$261K |
|
508
CarMax
KMX
$8.49B
| $264K | 0.02% |
+3,029
| New | +$229K |
|
509
UDR
UDR
$11.3B
| $263K | 0.02% |
+7,027
| New | +$259K |
|
510
Pentair
PNR
$9.17B
| $259K | 0.02% |
+3,028
| New | +$229K |
|
511
Immunocore
IMCR
$1.62B
| $256K | 0.02% |
3,944
+116
| +3% | +$7.96K |
|
512
Alliant Energy
LNT
$17.2B
| $256K | 0.02% |
+5,084
| New | +$249K |
|
513
NiSource
NI
$19.6B
| $254K | 0.02% |
+9,196
| New | +$242K |
|
514
CF Industries
CF
$20.2B
| $252K | 0.02% |
+3,030
| New | +$242K |
|
515
Bath & Body Works
BBWI
$3.41B
| $252K | 0.02% |
+5,036
| New | +$226K |
|
|
SLN
516
Silence Therapeutics
SLN
$787M
| $252K | 0.02% |
+11,656
| New | +$253K |
|
517
Lantheus
LNTH
$6.58B
| $252K | 0.02% |
+4,043
| New | +$238K |
|
|
WRK
518
DELISTED
WestRock Company
WRK
| $251K | 0.02% |
+5,085
| New | +$222K |
|
519
Healthpeak Properties
DOC
$14B
| $249K | 0.02% |
+13,260
| New | +$241K |
|
520
Best Buy
BBY
$19.3B
| $249K | 0.02% |
+3,030
| New | +$231K |
|
521
APA Corp
APA
$15.9B
| $244K | 0.02% |
+7,111
| New | +$225K |
|
522
Domino's
DPZ
$10.1B
| $242K | 0.02% |
487
-7
| -1% | -$3.04K |
|
523
Factset
FDS
$9.79B
| $241K | 0.01% |
530
-8
| -1% | -$3.73K |
|
524
Tapestry
TPR
$23.6B
| $241K | 0.01% |
+5,072
| New | +$218K |
|
525
Everest Group
EG
$14.6B
| $240K | 0.01% |
605
-9
| -1% | -$3.38K |
|
Similar funds
RG
LP
RCMU
SC
SO
NEOS Investment Management's Q1 2024 Portfolio in Review
As of Q1 2024, NEOS Investment Management held 582 positions worth $1.61B, up 53% from $1.06B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
NEOS Investment Management deployed $437M of net new capital in Q1 2024, opening 73 new positions and adding to 454 existing holdings. Its largest new stake was Keros Therapeutics: 14,264 shares worth $944K.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 36% a quarter earlier, followed by Healthcare and Communication Services.
On the sell side, the largest reduction was Goldman Sachs, an estimated $583K trimmed.
- NEOS Investment Management's largest Q1 2024 buy was Keros Therapeutics: 14,264 shares worth $944K.
- NEOS Investment Management added most to Microsoft in Q1 2024, an estimated $29.1M increase.
- NEOS Investment Management's biggest Q1 2024 reduction was Goldman Sachs, cutting an estimated $583K.
- NEOS Investment Management fully exited Vanguard Russell 2000 ETF in Q1 2024, selling an estimated $12.5M.
- NEOS Investment Management's ten largest holdings make up 34% of its $1.61B portfolio in Q1 2024.
- NEOS Investment Management opened 73 new positions and closed 16 in Q1 2024.
- NEOS Investment Management's portfolio value rose 53% quarter-over-quarter to $1.61B.
Based on NEOS Investment Management's 13F filing for Q1 2024, filed 13 May 2024.